307838969	307838969	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
84045759	84045759	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3682788	3682788	CD	B-NP	O
|	|	CC	I-NP	O
10/19/2006	10/19/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SYNCOPE	SYNCOPE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/20/2006	8/20/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/6/2006	8/6/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
PEKARA	PEKARA	NN	B-NP	O
,	,	,	O	O
EARNEST	EARNEST	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
Ton	Ton	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Myocardial	Myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
and	and	CC	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
running	run	VBG	I-VP	O
up	up	IN	B-ADVP	O
and	and	CC	I-ADVP	O
down	down	IN	I-ADVP	O
the	the	DT	B-NP	O
steps	step	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
8/10	8/10	CD	I-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
associated	associate	VBN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
note	note	NN	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
persisted	persist	VBD	B-VP	O
for	for	IN	B-PP	O
about	about	RB	B-NP	O
20	20	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
called	call	VBD	B-VP	O
the	the	DT	B-NP	O
EMS	EMS	NNP	I-NP	O
but	but	CC	B-PP	O
by	by	IN	B-PP	O
time	time	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
calling	call	VBG	I-VP	O
EMS	EMS	NNP	B-NP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
dissipating	dissipate	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
last	last	JJ	I-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
poor	poor	JJ	I-NP	O
historian	historian	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
recollection	recollection	NN	I-NP	O
of	of	IN	B-PP	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
or	or	CC	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
presented	present	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
172/79	172/79	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
88	88	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
additional	additional	JJ	B-NP	O
IV	IV	CD	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nitro	nitro	NN	B-NP	O
paste	paste	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1c	A1c	NN	I-NP	O
of	of	IN	B-PP	O
6.9	6.9	CD	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1.3	1.3	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Monopril	Monopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Felodipine	Felodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
each	each	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
truck	truck	NN	I-NP	O
driver	driver	NN	I-NP	O
who	who	WP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
wife	wife	NN	I-NP	O
in	in	IN	B-PP	O
Font	Font	NNP	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
but	but	CC	O	O
quit	quit	VBD	B-VP	O
about	about	RB	B-NP	O
five	five	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
40s	40	NNS	I-NP	I-cell_line
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.4	97.4	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
69	69	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/70	160/70	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
awake	awake	RB	B-ADVP	O
,	,	,	O	O
alert	alert	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
answered	answer	VBD	B-VP	O
the	the	DT	B-NP	O
questions	question	NNS	I-NP	O
slowly	slowly	RB	B-ADVP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
affect	affect	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
moist	moist	NN	B-NP	O
and	and	CC	I-NP	O
oropharynx	oropharynx	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
supple	supple	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II-XII	II-XII	NN	I-NP	B-protein
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
was	be	VBD	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
basic	basic	JJ	I-NP	B-protein
metabolic	metabolic	JJ	I-NP	I-protein
panel	panel	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BMP	BMP	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BUN	BUN	NN	B-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
and	and	CC	I-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.6	7.6	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
43.6	43.6	CD	B-NP	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
194	194	CD	I-NP	I-protein
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CPK	CPK	NN	I-NP	B-protein
of	of	IN	B-PP	O
84	84	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
desat	desat	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
88	88	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
CK-MB	CK-MB	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
was	be	VBD	B-VP	O
0.58	0.58	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
PACs	PAC	NNS	B-NP	B-cell_type
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
T-wave	T-wave	JJ	I-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
,	,	,	O	O
V6	V6	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
and	and	CC	O	O
aVL	aVL	NN	B-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
status	status	NN	I-NP	O
post	post	VBD	B-VP	O
an	an	DT	B-NP	O
RCA	RCA	NN	I-NP	O
stent	stent	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
flow-limiting	flow-limiting	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	B-protein
elevation	elevation	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
flow-limiting	flow-limiting	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
loaded	load	VBN	B-VP	O
with	with	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
q.	q.	NNP	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
lesion	lesion	NN	I-NP	O
estimated	estimate	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
about	about	RB	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
mid	mid	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
diffuse	diffuse	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
distal	distal	JJ	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
tubular	tubular	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
tubular	tubular	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
PA.	PA.	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
three-vessel	three-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
surgical	surgical	JJ	B-NP	O
revascularization	revascularization	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiothoracic	cardiothoracic	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
service	service	NN	I-NP	O
who	who	WP	B-NP	O
discussed	discuss	VBD	B-VP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
at	at	IN	B-PP	O
length	length	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
on	on	IN	B-PP	O
service	service	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
cardiothoracic	cardiothoracic	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
in	in	IN	B-PP	O
contact	contact	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
option	option	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
percutaneous	percutaneous	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
dementia	dementia	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
difficult	difficult	JJ	I-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
necessary	necessary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
following	follow	VBG	B-PP	O
CABG	CABG	NN	B-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
percutaneous	percutaneous	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
would	would	MD	B-VP	O
indeed	indeed	RB	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
option	option	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Cypher	Cypher	NNP	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
OM2	OM2	NN	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Cypher	Cypher	NNP	I-NP	O
stent	stent	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
non-diseased	non-diseased	JJ	I-NP	O
ostium	ostium	NN	I-NP	O
of	of	IN	B-PP	O
OM1	OM1	NN	B-NP	B-protein
and	and	CC	O	O
then	then	RB	O	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Cypher	Cypher	NNP	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
final	final	JJ	I-NP	O
angiograms	angiogram	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
or	or	CC	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
percutaneous	percutaneous	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PDA/PLV	PDA/PLV	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stenting	stenting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stenotic	stenotic	JJ	B-ADJP	O
and	and	CC	O	O
likely	likely	RB	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
refractory	refractory	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	I-VP	O
following	follow	VBG	I-VP	O
his	his	PRP$	B-NP	O
percutaneous	percutaneous	JJ	I-NP	O
interventions	intervention	NNS	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
including	include	VBG	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ruud	Ruud	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
repeat	repeat	NN	I-NP	O
percutaneous	percutaneous	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
with	with	IN	B-PP	O
basal	basal	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
septum	septum	NN	I-NP	O
basal	basal	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
segment	segment	NN	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypertension	hypertension	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	I-VP	O
exacerbated	exacerbate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
found	find	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
additional	additional	JJ	B-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
that	that	WDT	B-NP	O
include	include	VBP	B-VP	O
felodipine	felodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
150	150	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
dinitrate	dinitrate	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
and	and	CC	O	O
Monopril	Monopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
received	receive	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
after	after	IN	B-PP	O
ensuring	ensure	VBG	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
okay	okay	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
1.3	1.3	CD	I-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	I-NP	O
sodium	sodium	NN	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
.	.	.	O	O

Continue	Continue	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peri	peri	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
remained	remain	VBD	B-VP	O
within	within	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
range	range	NN	I-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
insulin	insulin	NN	B-NP	B-protein
and	and	CC	O	O
oral	oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
long	long	JJ	I-NP	O
and	and	CC	I-NP	O
short	short	JJ	I-NP	O
acting	act	VBG	I-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
including	include	VBG	B-PP	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nightly	nightly	RB	B-NP	O
NPH	NPH	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
multiinfarct	multiinfarct	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
and	and	CC	O	O
sundowning	sundowne	VBG	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
medications	medication	NNS	B-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
these	these	DT	B-NP	O
,	,	,	O	O
rather	rather	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
oriented	orient	VBN	I-VP	O
and	and	CC	O	O
spoke	spoke	VB	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
on	on	IN	B-PP	O
several	several	JJ	B-NP	O
occasions	occasion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
RPR	RPR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
TSH	TSH	NN	I-NP	O
and	and	CC	I-NP	O
B12	B12	NN	I-NP	B-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
RPR	RPR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subq	subq	NN	I-NP	I-protein
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
one	one	CD	I-NP	I-protein
tab	tab	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
x3	x3	CD	B-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Felodipine	Felodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Monopril	Monopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

FOLLOW	FOLLOW	RB	B-ADVP	O
UP	UP	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sferra	Sferra	NNP	I-NP	O
on	on	IN	B-PP	O
7/15/2006	7/15/2006	CD	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Asi	Asi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Care	Care	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lovern	Lovern	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
2/27/2006	2/27/2006	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Hosston	Hosston	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
draw	draw	VB	I-VP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
1/27/06	1/27/06	CD	B-NP	O
and	and	CC	O	O
page	page	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Cody	Cody	NNP	I-NP	O
Amparo	Amparo	NNP	I-NP	O
,	,	,	O	O
pager	pager	NN	B-NP	O
number	number	NN	I-NP	O
36157	36157	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	B-VP	O
reconcile	reconcile	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medication	medication	NN	I-NP	O
list	list	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medication	medication	NN	I-NP	O
list	list	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
clarify	clarify	VB	I-VP	O
any	any	DT	B-NP	O
discrepancies	discrepancy	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Toby	Toby	NNP	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
discuss	discuss	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sikkink	Sikkink	NNP	I-NP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
provided	provide	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
remains	remain	VBZ	B-VP	O
within	within	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
range	range	NN	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
entire	entire	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-0728869	0-0728869	CD	B-NP	O
HFFocus	HFFocus	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Brain	Brain	NNP	B-NP	O
A.	A.	NNP	I-NP	O
Battistini	Battistini	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Vall	Vall	NNP	I-NP	O
O	O	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Gail	Gail	NNP	B-NP	O
Cobane	Cobane	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Norgug	Norgug	NNP	I-NP	O
Atmar	Atmar	NNP	I-NP	O
Woodsol	Woodsol	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Lin	Lin	NNP	I-NP	O
,	,	,	O	O
Minnesota	Minnesota	NNP	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BENDLER	BENDLER	NNP	B-NP	O
,	,	,	O	O
RAYMON	RAYMON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WYBORNY	WYBORNY	NN	B-NP	O
,	,	,	O	O
RALPH	RALPH	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
0168115	0168115	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/7/06	10/7/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/7/06	10/7/06	CD	B-NP	O

